$AVTX
Avalo Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$14.99
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAvalo Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AVTX up today? It is at $14.99 (+0.00%), and our scanner flagged it 71 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AVTX spikes, and full due diligence on AVTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AVTX 71 times in the last 30 days. Create a free account to track $AVTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AVTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AVTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Sullivan Christopher Ryan Officer | Sold (automatic/other) | -12K 0.02% of company | sold 24% | 40K | $202K at $16.33 | Sep 16, 26 |
Sullivan Christopher Ryan Officer | Other | 12K 0.02% of company | added 31% | 52K | $122K at $9.88 | Sep 16, 26 |
Sullivan Christopher Ryan Officer | Sold (automatic/other) | -10K 0.02% of company | sold 20% | 40K | $179K at $17.62 | Sep 10, 26 |
Sullivan Christopher Ryan Officer | Other | 10K 0.02% of company | added 26% | 50K | $82K at $8.04 | Sep 10, 26 |
Doyle Mittie Officer | Sold (automatic/other) | -679 | sold 1.3% | 52K | $14K at $20.00 | Aug 28, 26 |
Doyle Mittie Officer | Other | 679 | added 1.3% | 52K | $5K at $8.04 | Aug 28, 26 |
Sullivan Christopher Ryan Officer | Sold (automatic/other) | -31K 0.06% of company | sold 44% | 40K | $622K at $20.05 | Aug 18, 26 |
Sullivan Christopher Ryan Officer | Other | 31K 0.06% of company | added 78% | 71K | $307K at $9.88 | Aug 18, 26 |
Sullivan Christopher Ryan Officer | Sold (automatic/other) | -38K 0.07% of company | sold 47% | 44K | $753K at $19.85 | Aug 17, 26 |
Sullivan Christopher Ryan Officer | Sold (automatic/other) | -4K | sold 8.6% | 40K | $75K at $19.94 | Aug 17, 26 |
Sullivan Christopher Ryan Officer | Other | 41K 0.08% of company | added 100% | 82K | $403K at $9.88 | Aug 17, 26 |
Doyle Mittie Officer | Sold (automatic/other) | -1K | sold 1.9% | 52K | $20K at $20.00 | Aug 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AVTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AVTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AVTX last traded at $14.99, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Avalo Therapeutics, Inc. Common Stock (AVTX) is next expected to report earnings on Thursday, November 5, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AVTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AVTX 71 times in the last 30 days.
AVTX (Avalo Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $804M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AVTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AVTX discussion
Sign in to ask a question or join the discussion.